A carregar...

Randomised, double blind, placebo controlled study of interferon β-1a in relapsing-remitting multiple sclerosis analysed by area under disability/time curves

OBJECTIVES—The commonly employed outcome measures on disability and relapse rates in treatment trials of relapsing-remitting multiple sclerosis have well demonstrated sensitivity to treatment effects, but their clinical interpretation is problematic. An alternative method of analysis, which is more...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liu, C., Blumhardt, L.
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 1999
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1736573/
https://ncbi.nlm.nih.gov/pubmed/10486390
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!